Codiak BioSciences, Inc. Additional Paid in Capital
Codiak BioSciences, Inc. had Additional Paid in Capital of $398.25 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2022-11-03
- 2022-09-30: Additional Paid in Capital $398.25M.
- 2022-06-30: Additional Paid in Capital $384.45M.
- 2022-03-31: Additional Paid in Capital $381.65M.
- 2021-12-31: Additional Paid in Capital $378.75M.
| Period end | Additional Paid in Capital |
|---|---|
| 2022-09-30 | $398.25M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $384.45M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $381.65M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $378.75M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $375.91M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $372.07M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $367.11M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $302.65M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.06M 10-Q · filed 2020-11-19 |
| 2019-12-31 | $2.00K 10-K · filed 2021-03-17 |